The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2010

Filed:

Nov. 02, 2004
Applicants:

Mark Stearns, Villanova, PA (US);

Youji HU, Gulph Mills, PA (US);

Min Wang, Gulph Mills, PA (US);

Inventors:

Mark Stearns, Villanova, PA (US);

Youji Hu, Gulph Mills, PA (US);

Min Wang, Gulph Mills, PA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); C12Q 1/00 (2006.01); G01N 33/567 (2006.01); G01N 33/574 (2006.01); G01N 33/48 (2006.01); G01N 1/00 (2006.01); G01N 1/18 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to novel nucleic acids encoding a mammalian PCADM-1 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, prostate cancer. The invention further relates to methods of detecting and treating prostate cancer, comprising modulating or detecting PCADM-1 expression and/or production and activity of PCADM-1 polypeptide. Further, the invention relates to novel assays for the identification of DNA-binding proteins and the double-stranded oligonucleotide sequences that specifically bind with them. Finally, the invention relates to DNAZYMs or DNA enzymes which specifically bind PCADM-1 mRNA to inhibit PCADM-1 gene expression and thereby destroy tumor cells and tumor tissue.


Find Patent Forward Citations

Loading…